Latest News

Browse by Company

  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Apex Labs
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clearmind Medicine
  • Clerkenwell Health
  • Compass Pathways
  • Core One Labs
  • Cybin
  • Cybin Corp
  • Delic Corp
  • Delix Therapeutics
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Enosis Therapeutics
  • Entheon Biomedical
  • Entheos Foundation
  • Enveric Biosciences
  • Field Trip
  • Field Trip Health
  • Field Trip Health & Wellness
  • Filament Health
  • Fireside Project
  • GH Research
  • Gilgamesh Pharmaceuticals
  • GreenStar Biosciences
  • Havn Life
  • HAVN Life Sciences
  • Hollister Biosciences
  • Incannex Health
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • Lusaris Therapeutics
  • MagicMed
  • MAPS
  • Mind Cure
  • MINDCURE
  • Mindleap
  • MindMed
  • MindMedicine
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Perception Neuroscience
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera
  • Psilera Bioscience
  • PsyBio
  • PsyBio Therapeutics
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Reunion Neuroscience
  • Revive Therapeutics
  • Seelos Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • Sunstone Therapies
  • SYNTAC Institute
  • Synthesis Institute
  • Terran Biosciences
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Transcend Therapeutics
  • Tryp Therapeutics
  • Universal Ibogaine
  • Unlimited Sciences
  • Usona Institute
  • Wake Network
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
All
  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Apex Labs
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clearmind Medicine
  • Clerkenwell Health
  • Compass Pathways
  • Core One Labs
  • Cybin
  • Cybin Corp
  • Delic Corp
  • Delix Therapeutics
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Enosis Therapeutics
  • Entheon Biomedical
  • Entheos Foundation
  • Enveric Biosciences
  • Field Trip
  • Field Trip Health
  • Field Trip Health & Wellness
  • Filament Health
  • Fireside Project
  • GH Research
  • Gilgamesh Pharmaceuticals
  • GreenStar Biosciences
  • Havn Life
  • HAVN Life Sciences
  • Hollister Biosciences
  • Incannex Health
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • Lusaris Therapeutics
  • MagicMed
  • MAPS
  • Mind Cure
  • MINDCURE
  • Mindleap
  • MindMed
  • MindMedicine
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Perception Neuroscience
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera
  • Psilera Bioscience
  • PsyBio
  • PsyBio Therapeutics
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Reunion Neuroscience
  • Revive Therapeutics
  • Seelos Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • Sunstone Therapies
  • SYNTAC Institute
  • Synthesis Institute
  • Terran Biosciences
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Transcend Therapeutics
  • Tryp Therapeutics
  • Universal Ibogaine
  • Unlimited Sciences
  • Usona Institute
  • Wake Network
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
From Senate to Psychedelics- Kyrsten Sinema’s Ibogaine Advocacy Playbook
Interviews

From Senate to Psychedelics: Kyrsten Sinema’s Ibogaine Advocacy Playbook

Oregon Psilocybin Services Tracker Q1 2025
Analysis

Oregon Psilocybin Services Tracker: Q1 2025

Reconstructing Meaning- Chris Timmermann on the Neurophenomenology of Psychedelics
Interviews

Reconstructing Meaning: Chris Timmermann on the Neurophenomenology of Psychedelics

Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model
Analysis

Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Analysis

Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study

Beckley Execs Talk Phase 2b Data, Competition, and Phase 3 Plans
Interviews

Beckley Execs Talk Phase 2b Data, Competition, and Phase 3 Plans

Beyond the Endpoint- Industry Voices Reflect on Compass’ Phase 3 Readout
Analysis

Beyond the Endpoint: Industry Voices Reflect on Compass’ Phase 3 Readout

Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber; Judge Recommends Schedule I Placement for DOI and DOC
Psychedelic Bulletin

Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber; Judge Recommends Schedule I Placement for DOI and DOC